Anna deFazio Selected Research

Anna deFazio Research Topics

Disease

28	Neoplasms (Cancer) 01/2021 - 05/2002
26	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 11/2008
9	Carcinoma (Carcinomatosis) 01/2021 - 02/2009
7	Ovarian Epithelial Carcinoma 01/2019 - 03/2011
5	Breast Neoplasms (Breast Cancer) 01/2019 - 10/2002
2	Endometrioid Carcinoma 04/2014 - 08/2013
1	Prostatic Neoplasms (Prostate Cancer) 01/2020
1	Sarcoma (Soft Tissue Sarcoma) 11/2018
1	Endometriosis 05/2017
1	Cysts 03/2011
1	Inflammation (Inflammations) 03/2011
1	Sleep Initiation and Maintenance Disorders (Insomnia) 12/2009
1	Adenocarcinoma 11/2008
1	Endometrial Stromal Sarcoma 04/2004

Drug/Important Bio-Agent (IBA)

7	PlatinumIBA 01/2018 - 05/2002
5	Biomarkers (Surrogate Marker)IBA 01/2019 - 08/2013
5	DNA (Deoxyribonucleic Acid)IBA 07/2013 - 02/2009
3	Adenosine Triphosphate (ATP)IBA 10/2020 - 05/2014
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2019 - 05/2014
3	Proteins (Proteins, Gene)FDA Link 01/2017 - 02/2009
3	Hormones (Hormone)IBA 08/2013 - 10/2002
2	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 12/2015
2	ChromatinIBA 01/2021 - 12/2016
2	taxaneIBA 01/2018 - 02/2016
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2018 - 07/2012
2	Oral ContraceptivesIBA 05/2017 - 04/2014
2	Small Interfering RNA (siRNA)IBA 04/2011 - 11/2008
1	Biological ProductsIBA 10/2020
1	Peptides (Polypeptides)IBA 01/2020
1	4- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2019
1	Estrogen ReceptorsIBA 01/2019
1	Anastrozole (Arimidex)FDA LinkGeneric 01/2019
1	paragonIBA 01/2019
1	CA-125 Antigen (CA 125 Antigen)IBA 11/2018
1	Mitogen-Activated Protein KinasesIBA 11/2018
1	dabrafenibIBA 11/2018
1	TransducinIBA 01/2018
1	Retinoblastoma ProteinIBA 01/2018
1	rucaparibIBA 01/2018
1	Thymidylate SynthaseIBA 01/2018
1	cyclo(Arg-Pro) (CI 4)IBA 05/2017
1	AntigensIBA 05/2017
1	Glycoproteins (Glycoprotein)IBA 05/2017
1	Analgesics (Analgesic Drugs)IBA 04/2017
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 04/2017
1	UbiquitinIBA 12/2016
1	Ligases (Synthetase)IBA 12/2016
1	Genetic Markers (Genetic Marker)IBA 03/2016
1	Membrane Proteins (Integral Membrane Proteins)IBA 02/2016
1	MicroRNAs (MicroRNA)IBA 01/2016
1	3' Untranslated Regions (3' UTR)IBA 01/2016
1	Histones (Histone)IBA 12/2015
1	Indicators and Reagents (Reagents)IBA 12/2014
1	Subfamily A ATP Binding Cassette TransporterIBA 07/2014
1	LipidsIBA 07/2014
1	CholesterolIBA 07/2014
1	Transcription Factors (Transcription Factor)IBA 07/2014
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 07/2014
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2014
1	Transforming Growth Factor beta3 (TGF beta 3)IBA 04/2014
1	Galectin 1 (LGALS1)IBA 04/2014
1	betaglycan (TGFBR3)IBA 04/2014
1	Transforming Growth Factor-beta Type I ReceptorIBA 04/2014
1	Interleukin-6 (Interleukin 6)IBA 04/2014
1	Interleukin-15 (Interleukin 15)IBA 04/2014
1	Interleukin-8 (Interleukin 8)IBA 04/2014
1	Interleukin-10 (Interleukin 10)IBA 04/2014
1	liposomal doxorubicin (Doxil)FDA Link 08/2012
1	Epithelial Cell Adhesion MoleculeIBA 03/2011
1	Telomerase (Telomerase Reverse Transcriptase)IBA 07/2010
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 12/2009
1	OligonucleotidesIBA 02/2009
1	Cisplatin (Platino)FDA LinkGeneric 11/2008
1	villinIBA 06/2008
1	Arginine (L-Arginine)FDA Link 06/2008
1	Keratin-8 (Keratin 8)IBA 06/2008
1	CalciumIBA 06/2008
1	Progestins (Progestagens)IBA 04/2004
1	Protein Isoforms (Isoforms)IBA 04/2004
1	progesterone receptor AIBA 04/2004
1	4-phenylbutyric acid (Buphenyl)FDA Link 10/2002
1	Butyrates (Butyrate)IBA 10/2002

Therapy/Procedure

12	Drug Therapy (Chemotherapy) 01/2021 - 05/2002
6	Therapeutics 01/2018 - 04/2004
2	Cytoreduction Surgical Procedures 02/2016 - 12/2015
1	Aftercare (After-Treatment) 01/2018
1	Tubal Sterilization (Tubal Ligation) 05/2017
1	Combination Drug Therapy (Combination Chemotherapy) 05/2015
1	Chemoprevention 10/2002